Before getting YERVOY® (ipilimumab)
You’ll likely have a lot of questions and concerns about your metastatic melanoma treatment. So write down what you want to ask—and tell—and what your oncologist needs to clarify. Talk over what’s important to you. Be heard. And make sure your doctor understands your goals.
Some important information is up to you to provide—right from the start
Before you are given YERVOY® (ipilimumab), tell your healthcare provider about all your health problems if you:
- have an active condition where your immune system attacks your body (autoimmune disease), such as ulcerative colitis, Crohn’s disease, lupus, or sarcoidosis
- had an organ transplant, such as a kidney transplant
- have liver damage from diseases or drugs
- have any other medical conditions
- are pregnant or plan to become pregnant. YERVOY may cause stillbirth, premature delivery, and/or death of your unborn baby
- are breast-feeding. It is advised that nursing mothers do not breast-feed while taking YERVOY
Tell your healthcare provider about all the medicines you take, including all prescription and non-prescription medicines, steroids or other medicines that lower your immune response, vitamins, and herbal supplements.
Know the medicines you take. Keep a list to show your doctors and pharmacists each time you get a new medicine. And make sure it’s always up to date.
Don’t start taking any new medicine before you talk with the healthcare provider who prescribes YERVOY for you.
What if your doctor recommends a BRAF test?
If you’ve just been diagnosed, your doctor will likely do some tests on your melanoma tumor(s), which may include a genetic test to detect something called your BRAF status. A BRAF positive status means the tumor(s) has a damaged BRAF gene. This gene is found in about half of all metastatic melanoma tumors.
Ask your doctor if YERVOY could be right for you, regardless of your BRAF status
The YERVOY clinical study did not test metastatic melanoma patients’ tumors for BRAF status and therefore may have included both BRAF negative and BRAF positive patients. As a result, it’s not known what, if any, clinical relevance BRAF status has with respect to YERVOY.
What else should I know about YERVOY treatment?
And of course, talk to your oncologist
Remember, your doctor is the best source of information about your disease and which treatment may be best for you. This website is designed to give you a better understanding of YERVOY, but there’s no substitute for a face-to-face conversation with your doctor about your treatment options.